2.4 mg semaglutide to tirzepatide vs. for Weight Loss BodyByBariatrics

Some medications should be avoided due to the risk of significant interactions, while monitoring is essential to ensure safety and efficacy

OASIS 3: A 44-week efficacy and safety phase 3a trial comparing once-daily oral semaglutide (50 mg) to placebo for weight loss in 200 Chinese adults with obesity or overweight with one or more comorbidities

Riding the success in obesity, Eli Lilly announced that they would begin pursuing large studies to determine if GLP-1 agonists reduce alcohol abuse and drug use

Those using compounded semaglutide from multi-dose vials sometimes find it easier to draw up two smaller injections than one larger one, particularly at higher doses where injection volume becomes uncomfortable